Growth in PHEX-associated X-linked hypophosphatemic rickets: The importance of early treatment

Pediatric Nephrology

Volumn 27, Issue 4, 2012, Pages 581-588

  Quinlan, Catherine ^a   Guegan, Katie ^b   Offiah, Amaka ^c   Neill, Richard O' ^d   Hiorns, Melanie P ^d   Ellard, Sian ^b   Bockenhauer, Detlef ^a   Van't Hoff, William ^a   Waters, Aoife M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

1,25 dihydroxyvitamin D3; Endopeptidases; Growth; Homologies; Persistent hypophosphatemia; Phosphate therapy; Phosphateregulating gene; X linked hypophosphatemia; Xchromosome

Indexed keywords

CALCITRIOL; PHOSPHATE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; BONE DENSITY CONSERVATION AGENT; PHEX PROTEIN, HUMAN;

AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; GENDER; GENE MUTATION; GENOTYPE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; X LINKED HYPOPHOSPHATEMIC RICKETS; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUTATION;

BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; FEMALE; GROWTH AND DEVELOPMENT; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; INFANT; MALE; MUTATION; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHATES; RETROSPECTIVE STUDIES;

EID: 84862301501     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2046-z     Document Type: Article

References (35)

1. Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabedian M, Jehan F (2009) PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 125:401-411
2. The HYP consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136
3. Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: An inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638-1649
4. Yan X, Yokote H, Jing X, Yao L, Sawada T, Zhang Y, Liang S, Sakaguchi K (2005) Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells. Genes Cells 10:489-502 (Pubitemid 40590366)
5. Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, Xie Y, Drezner MK (2008) Aberrant PHEX function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest 118:722-734 (Pubitemid 351206560)
6. Glorieux FH,Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023-1031 (Pubitemid 10025213)
7. Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK (1985) Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest 75:1858-1868 (Pubitemid 15237795)
8. Costa T, Marie PJ, Scriver CR, Cole DE, Reade TM, Nogrady B, Glorieux FH, Delvin EE (1981) X-linked hypophosphatemia: Effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab 52:463-472 (Pubitemid 11136557)
9. Borghi MM, Coates V, Omar HA (2005) Evaluation of stature development during childhood and adolescence in individuals with familial hypophosphatemic rickets. Scientific World Journal 5:868-873
10. Miyamoto J, Koto S, Hasegawa Y (2000) Final height of Japanese patients with X-linked hypophosphatemic rickets: Effect of vitamin D and phosphate therapy. Endocr J 47:163-167 (Pubitemid 30399422)
11. Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591-3597 (Pubitemid 37034500)
12. Kruse K, Hinkel GK, Griefahn B (1998) Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr 157:894-900 (Pubitemid 28506548)
13. Verge CF, Cowell CT, Howard NJ, Donaghue KC, Silink M (1993) Growth in children with X-linked hypophosphataemic rickets. Acta Paediatr Suppl 388:70-75, discussion 76 (Pubitemid 23152531)
14. Chan JC, Lovinger RD, Mamunes P (1980) Renal hypophosphatemic rickets: Growth acceleration after long-term treatment with 1, 25-dihydroxyvitamin-D3. Pediatrics 66:445-454 (Pubitemid 10001153)
15. McEnery PT, Silverman FN, West CD (1972) Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets. J Pediatr 80:763-774
16. Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J (1990) X linked hypophosphataemia: Treatment, height gain, and nephrocalcinosis. Arch Dis Child 65:1125-1128 (Pubitemid 20330963)
17. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843-1848
18. Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE (1981) Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3. J Pediatr 99:16-25 (Pubitemid 11046412)
19. Glorieux FH, Scriver CR, Reade TM, Goldman H, Roseborough A (1972) Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 287:481-487
20. Jehan F, Gaucher C, Nguyen TM, Walrant-Debray O, Lahlou N, Sinding C, Dechaux M, Garabedian M (2008) Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment. Jf Clin Endocrinol Metab 93:4672-4682
21. Stickler GB, Morgenstern BZ (1989) Hypophosphataemic rickets: Final height and clinical symptoms in adults. Lancet 2:902-905
22. Chesney RW, Mazess RB, Rose P, Hamstra AJ, De Luca HF, Breed AL (1983) Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71:559-567 (Pubitemid 13116592)
23. Friedman NE, Lobaugh B, Drezner MK (1993) Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 76:839-844 (Pubitemid 23110824)
24. Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58:329-333 (Pubitemid 41099882)
25. Patriquin H, Robitaille P (1986) Renal calcium deposition in children: Sonographic demonstration of the Anderson-Carr progression. AJR Am J Roentgenol 146:1253-1256 (Pubitemid 16099556)
26. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO (2001) Mutational analysis and genotypephenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clinl Endocrinol Metab 86:3889-3899 (Pubitemid 32755994)
27. Boskey A, Frank A, Fujimoto Y, Spevak L, Verdelis K, Ellis B, Troiano N, Philbrick W, Carpenter T (2009) The PHEX transgene corrects mineralization defects in 9 month-old hypophosphatemic mice. Calcif Tissue Int 84:126-137
28. Qiu ZQ, Travers R, Rauch F, Glorieux FH, Scriver CR, Tenenhouse HS (2004) Effect of gene dose and parental origin on bone histomorphometry in X-linked hyp mice. Bone 34:134-139 (Pubitemid 38142441)
29. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L (1995) Effect of 1, 25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 10:424-431
30. Kooh SW, Binet A, Daneman A (1994) Nephrocalcinosis in Xlinked hypophosphataemic rickets: Its relationship to treatment, kidney function, and growth. Clin Invest Med 17:123-130 (Pubitemid 24167319)
31. Patzer L, van't Hoff W, Shah V, Hallson P, Kasidas GP, Samuell C, de Bruyn R, Barratt TM, Dillon MJ (1999) Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren. J Pediatr 135:611-617 (Pubitemid 30180452)
32. Schonaue E, Kruse K, Bohles HJ, Sewell AC (1992) More evidence for hyperoxaluria in phosphate-treated X-linked familial hypophosphataemic rickets. Eur J Pediatr 151:390
33. Alon U, Donaldson DL, Hellerstein S, Warady BA, Harris DJ (1992) Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the hyp mouse. J Pediatr 120:899-905
34. Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111:700-704 (Pubitemid 18017897)
35. Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD (2008) Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clinical J Am Soc Nephrol 3:658-664